Merck Collaborates with Medisafe to Improve Medication Adherence
Merck announced collaboration with US-based Medisafe, which aims to help cardiometabolic patients in managing medication intake and adherence to prescribed treatment through digital offering
Merck patients from various countries will be able to access a customized version of Medisafe’s mobile platform. The digital platform will combine reminders, motivation and support systems, targeted content, coupons, and interventions in their local language. This digital solution will complement Merck’s current offering of Primary Care medicines for cardiometabolic conditions, which includes treatments for type 2 diabetes, thyroid disorders, and cardiovascular diseases.
The first three countries where patients receiving Merck’s primary care medicines will have access to a customized version of Medisafe will be Brazil, Russia, and Mexico. Medisafe is a medication management and adherence solution that is invested by mVentures. Its mobile platform was named top app for medication management by November 2017 IQVIA (Quintiles IMS) report and has received endorsements from the American Pharmacy Association, Journal of Medical Internet Research (JMIR), and Ranked Health. “We are confident that offering such a solution to our patients has the potential to significantly improve medication adherence by giving patients and healthcare providers tools to organize, understand and manage their medications,” said Simon Sturge, chief operating officer at Merck´s Biopharma business.
The full benefits of medications in the treatment of chronic diseases are not realized by patients due to poor adherence to treatment regimens. Factors that contribute to poor medication adherence are many and include those that are related to patients, physicians, and healthcare systems. As a result, understanding of the underlying causes of poor medication adherence is limited. The collaboration is expected to provide overall insights for patient behaviors through aggregated and de-identified data collected by Medisafe to improve chronic disease management.
You may be interested
Smart Nanotechnology Enlivens Wooden Ships and ArtifactsMohit Joshi - January 28, 2019
Scientists developed an innovative approach using ‘smart’ nanocomposites to conserve 16th-century British warship, the Mary Rose, and its artifacts. Shipwrecks are preserved in sediments under cold water,…
Researchers Discovered New Properties of Ferroelectric CrystalMohit Joshi - January 25, 2019
Researchers discovered new properties of ferroelectric crystal, according to a study published on July 10, 2018. This study was conducted by a team of researchers from China.…
Researchers Develop Novel Antibody to Knockdown of Protein in VertebratesMohit Joshi - January 24, 2019
Researchers from Technische Universität Dresden developed a synthetic antibody that improves functional analysis of proteins. A research led by Dr. Jörg Mansfeld of the Biotechnology Center of…